newdrugapprovals.org
Sanofi And Regeneron Report Positive Proof-of-Concept Data For Dupilumab, An IL-4R Alpha Antibody, In Atopic Dermatitis
Monoclonal antibody Source Human Target IL4 receptor alpha Treatment of atopic diseases Immunoglobulin, anti-(human interleukin 4 receptor α) (human REGN668 heavy chain), disulfide with huma…